Cumberland Pharmaceuticals (CPIX) Acquisitions (2018 - 2025)

Cumberland Pharmaceuticals' (CPIX) quarterly Acquisitions came in at $1.0 million in Q4 2025, up 68.33% quarter-over-quarter from $611600.0 in Q3 2025.

Cumberland Pharmaceuticals (CPIX) Acquisitions (2018 - 2025) Analysis & Trends

Cumberland Pharmaceuticals has disclosed Acquisitions across 3 years of filings, most recently posting $1.0 million for Q4 2025.

  • Acquisitions for Q4 2025 came in at $1.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $2.5 million (changed N/A YoY), and the FY2025 annual result was $2.5 million, changed N/A from the prior year.
  • Acquisitions came in at $1.0 million for Q4 2025 at Cumberland Pharmaceuticals, up from $611600.0 in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $13.5 million in Q1 2022 to a low of -$326262.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.09 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 137.87 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Cumberland Pharmaceuticals 86.62 Mn 75.28 Mn 7.20 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.03 Mn
Sep 30, 2025 611,600.00
Jun 30, 2025 -326,262.00
Mar 31, 2025 1.16 Mn
Mar 31, 2022 13.50 Mn
Dec 31, 2018 20.00 Mn